ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action
R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
Novel Biology, Novel Utility, & the Illusion of Skill: What to develop? What to reward?
New pipeline analysis: Cancer projects were funded 17x more than antibacterials during 2011-2020
In Praise of Non-Inferiority
Developing antibiotics for children: There are no easy answers
Lancet: 10-20-30 targets to address AMR by 2030
Push! Pull! Push! Pull! / Highlights from Davos 2018
FDA workshop: Insights on inhaled antifungals and antibacterials
FDA and EMA regulatory updates / Fireside chat during the 4th AMR Conference
Modeling the value of an effective antibiotic — Megiddo et al.
FDA analysis of 40-years of antibacterial development: Dheman et al.
UK to expand NHS Subscription Pilot! Consultation Period launches
Non-traditional antibiotics: A pipeline review and an analysis of key development challenges
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet